Oude Egberink Rik, Zegelaar Helen M, El Boujnouni Najoua, Versteeg Elly M M, Daamen Willeke F, Brock Roland
Department of Biochemistry, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Geert Grooteplein 28, 6525 GA Nijmegen, The Netherlands.
Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Geert Grooteplein 28, 6525 GA Nijmegen, The Netherlands.
Pharmaceutics. 2022 Aug 2;14(8):1619. doi: 10.3390/pharmaceutics14081619.
In our aging society, the number of patients suffering from poorly healing bone defects increases. Bone morphogenetic proteins (BMPs) are used in the clinic to promote bone regeneration. However, poor control of BMP delivery and thus activity necessitates high doses, resulting in adverse effects and increased costs. It has been demonstrated that messenger RNA (mRNA) provides a superior alternative to protein delivery due to local uptake and prolonged expression restricted to the site of action. Here, we present the development of porous collagen scaffolds incorporating peptide-mRNA nanoparticles (NPs). Nanoparticles were generated by simply mixing aqueous solutions of the cationic cell-penetrating peptide PepFect14 (PF14) and mRNA. Peptide-mRNA complexes were uniformly distributed throughout the scaffolds, and matrices fully preserved cell attachment and viability. There was a clear dependence of protein expression on the incorporated amount of mRNA. Importantly, after lyophilization, the mRNA formulation in the collagen scaffolds retained activity also at 4 °C over two weeks. Overall, our results demonstrate that collagen scaffolds incorporating peptide-mRNA complexes hold promise as off-the-shelf functional biomaterials for applications in regenerative medicine and constitute a viable alternative to lipid-based mRNA formulations.
在我们这个老龄化社会中,患有难以愈合的骨缺损的患者数量不断增加。骨形态发生蛋白(BMPs)在临床上用于促进骨再生。然而,对BMP递送及活性的控制不佳需要高剂量使用,这会导致不良反应并增加成本。已证明信使核糖核酸(mRNA)由于可被局部摄取且表达局限于作用部位而延长,因此是蛋白质递送的一种更优替代方案。在此,我们展示了包含肽 - mRNA纳米颗粒(NPs)的多孔胶原支架的研发情况。通过简单混合阳离子细胞穿透肽PepFect14(PF14)和mRNA的水溶液来制备纳米颗粒。肽 - mRNA复合物均匀分布于整个支架中,并且基质完全保留了细胞附着和活力。蛋白质表达明显依赖于mRNA的掺入量。重要的是,冻干后,胶原支架中的mRNA制剂在4℃下两周内仍保持活性。总体而言,我们的结果表明,包含肽 - mRNA复合物的胶原支架有望成为再生医学应用中现成的功能性生物材料,并且是基于脂质的mRNA制剂的可行替代方案。